Lynch syndrome: genes and variants
Explore variant evidence for Lynch syndrome across 10 analyzed proteins (MLH1, MSH2, MSH6, PMS2, CHEK2 and 5 more). Linked ClinVar records include 189 pathogenic or likely pathogenic variants, 5,385 variants of uncertain significance and 1,342 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Lynch syndrome
MLH1: DNA mismatch repair protein Mlh1
The protein partners with PMS2 to form MutL alpha, a core complex in post-replicative DNA mismatch repair. By helping correct copying errors in DNA, MLH1 protects genome stability, and inherited MLH1 variants are a major cause of Lynch syndrome.
120 ClinVar pathogenic / likely pathogenic and 1,437 uncertain variants in MLH1 have source records linked to Lynch syndrome. Association strength is not clinical gene validity.
MSH2: DNA mismatch repair protein Msh2
The protein forms mismatch-recognition complexes with MSH6 or MSH3 that detect base mismatches and insertion-deletion loops in DNA. This first step of mismatch repair helps preserve genome integrity, and inherited MSH2 variants are associated with Lynch syndrome.
26 ClinVar pathogenic / likely pathogenic and 1,381 uncertain variants in MSH2 have source records linked to Lynch syndrome. Association strength is not clinical gene validity.
MSH6: DNA mismatch repair protein Msh6
Together with MSH2, it recognizes single-base mismatches and small insertion-deletion loops during DNA replication and initiates mismatch repair. Germline loss-of-function variants cause Lynch syndrome, while biallelic variants can cause constitutional mismatch-repair deficiency.
23 ClinVar pathogenic / likely pathogenic and 1,803 uncertain variants in MSH6 have source records linked to Lynch syndrome. Association strength is not clinical gene validity.
PMS2: Mismatch repair endonuclease PMS2
Together with MLH1, it provides endonuclease activity needed to complete DNA mismatch repair after replication errors are recognized. Germline loss-of-function variants cause Lynch syndrome, while biallelic variants cause constitutional mismatch-repair deficiency.
19 ClinVar pathogenic / likely pathogenic and 2,006 uncertain variants in PMS2 have source records linked to Lynch syndrome. Association strength is not clinical gene validity.
CHEK2: Serine/threonine-protein kinase Chk2
It propagates DNA-damage checkpoint signals to proteins controlling cell-cycle arrest, repair, and apoptosis. Germline loss-of-function variants confer moderate cancer susceptibility, especially for breast cancer, while risk estimates depend on the specific allele and family context.
1 ClinVar pathogenic / likely pathogenic and 20 uncertain variants in CHEK2 have source records linked to Lynch syndrome. Association strength is not clinical gene validity.
MLH3: DNA mismatch repair protein Mlh3
It partners with other mismatch-repair proteins and also participates in meiotic crossover formation. Biallelic or monoallelic variants have been investigated in cancer predisposition, but the clinical significance of many MLH3 variants remains less firmly established than for core Lynch-syndrome genes.
0 ClinVar pathogenic / likely pathogenic and 14 uncertain variants in MLH3 have source records linked to Lynch syndrome. Association strength is not clinical gene validity.
EPCAM: Epithelial cell adhesion molecule
It supports epithelial organization and signaling at cell-cell interfaces. Deletions extending through its 3-prime end can silence neighboring MSH2 and cause Lynch syndrome, while biallelic loss-of-function variants cause congenital tufting enteropathy.
0 ClinVar pathogenic / likely pathogenic and 26 uncertain variants in EPCAM have source records linked to Lynch syndrome. Association strength is not clinical gene validity.
TGFBR2: TGF-beta receptor type-2
It binds TGF-beta ligands and activates TGFBR1 to initiate canonical and noncanonical signaling. Germline pathogenic variants cause Loeys-Dietz syndrome type 2, while somatic loss can remove growth-suppressive TGF-beta responses in cancer.
0 ClinVar pathogenic / likely pathogenic and 19 uncertain variants in TGFBR2 have source records linked to Lynch syndrome. Association strength is not clinical gene validity.
CTNNA1: Catenin alpha-1
It links cadherin-catenin adhesion complexes to the actin cytoskeleton and helps maintain epithelial integrity and tissue architecture. Germline loss-of-function variants can predispose to diffuse gastric cancer, while biallelic variants can cause severe epithelial and skin disease.
0 ClinVar pathogenic / likely pathogenic and 14 uncertain variants in CTNNA1 have source records linked to Lynch syndrome. Association strength is not clinical gene validity.
PMS1: PMS1 protein homolog 1
It participates in DNA mismatch repair through complexes with MLH-family proteins, although its role is less central than that of PMS2 in canonical MutLalpha activity. Germline variants have been investigated in cancer predisposition, but many reported associations remain less definitive than core Lynch-syndrome genes.
0 ClinVar pathogenic / likely pathogenic and 6 uncertain variants in PMS1 have source records linked to Lynch syndrome. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): CDH1, CDKN1B and FAN1.
ClinVar pathogenic and likely pathogenic variants linked to Lynch syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| MLH1 F80V | 80 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 T82I | 82 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 T82A | 82 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 K84E | 84 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 E102K | 102 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 E102D | 102 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 T117R | 117 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 M1T | 1 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 M1K | 1 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 M1R | 1 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 A21E | 21 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 A21V | 21 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 N38K | 38 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 D63V | 63 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 C77Y | 77 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 C77R | 77 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 G101D | 101 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 G101S | 101 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 R182G | 182 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 R265S | 265 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 R265P | 265 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 S295R | 295 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 N306K | 306 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 M1I | 1 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 P28L | 28 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 I107R | 107 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 R127K | 127 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 V185G | 185 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 R226L | 226 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 R226Q | 226 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 S295N | 295 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 K311E | 311 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 I19F | 19 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 A29G | 29 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 A29S | 29 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 R100P | 100 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 A111V | 111 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 A128P | 128 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 R182K | 182 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 S295G | 295 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 D304V | 304 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 H308P | 308 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 L749P | 749 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 R755G | 755 | Pathogenic / likely pathogenic (★★★) | |
| MSH2 V695M | 695 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 S247P | 247 | Pathogenic / likely pathogenic (★★★) | |
| MSH6 A1055P | 1055 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 I25F | 25 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 K70E | 70 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 G147E | 147 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 V152G | 152 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 L155R | 155 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 G244D | 244 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 L260R | 260 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 I276R | 276 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 L559P | 559 | Interaction with EXO1 | Pathogenic / likely pathogenic (★★★) |
| MLH1 H718P | 718 | Pathogenic / likely pathogenic (★★★) | |
| MSH2 P349R | 349 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 A281V | 281 | Pathogenic / likely pathogenic (★★★) | |
| MLH1 Q701H | 701 | Pathogenic / likely pathogenic (★★★) |
Showing 60 of 189.
Uncertain variants prioritized for review in Lynch syndrome
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| MLH1 D63Y | 63 | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; D63H at the same position is pathogenic; REVEL 0.989 | |
| MLH1 P28S | 28 | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; P28L at the same position is pathogenic; REVEL 0.878 | |
| MLH1 V152M | 152 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; V152G at the same position is pathogenic; REVEL 0.855 | |
| MLH1 D304G | 304 | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; D304V at the same position is pathogenic; REVEL 0.968 | |
| MSH2 V695L | 695 | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; V695M at the same position is pathogenic; REVEL 0.883 | |
| MLH1 N306S | 306 | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; N306D at the same position is pathogenic; REVEL 0.912 | |
| MLH1 L260H | 260 | Conflicting reports (★) | +6: L260R at the same position is pathogenic; REVEL 0.951 | |
| MLH1 R265H | 265 | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; R265S at the same position is pathogenic; REVEL 0.824 | |
| MLH1 Y684S | 684 | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; Y684D at the same position is pathogenic; REVEL 0.920 | |
| MSH2 A604T | 604 | Interaction with EXO1 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; A604D at the same position is pathogenic; REVEL 0.844 |
| MSH2 N671S | 671 | Interaction with EXO1 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; N671Y at the same position is pathogenic; REVEL 0.775 |
| MLH1 E102Q | 102 | Uncertain (★) | +6: 6 other pathogenic changes within 3 positions; E102D at the same position is pathogenic; REVEL 0.931 | |
| MSH2 F694V | 694 | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; F694I at the same position is pathogenic; REVEL 0.938 | |
| MSH6 G770S | 770 | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; G770C at the same position is pathogenic; REVEL 0.951 | |
| MLH1 R100Q | 100 | Uncertain (★★) | +6: 9 other pathogenic changes within 3 positions; R100P at the same position is pathogenic; REVEL 0.927 | |
| MLH1 R265L | 265 | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; R265S at the same position is pathogenic; REVEL 0.973 | |
| MLH1 T82S | 82 | Uncertain (★★) | +6: 7 other pathogenic changes within 3 positions; T82I at the same position is pathogenic; REVEL 0.856 | |
| MLH1 H308Y | 308 | Uncertain (★★) | +6: 4 other pathogenic changes within 3 positions; H308P at the same position is pathogenic; REVEL 0.931 | |
| MSH6 A1154V | 1154 | Uncertain (★★) | +6: A1154D at the same position is pathogenic; REVEL 0.944 | |
| MLH1 N306I | 306 | Uncertain (★★) | +6: 4 other pathogenic changes within 3 positions; N306D at the same position is pathogenic; REVEL 0.967 | |
| MLH1 D304N | 304 | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; D304V at the same position is pathogenic; REVEL 0.882 | |
| MSH2 P696A | 696 | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; P696R at the same position is pathogenic; REVEL 0.904 | |
| MSH2 L310F | 310 | Uncertain (★★) | +6: L310R at the same position is pathogenic; REVEL 0.956 | |
| MSH2 L310H | 310 | Uncertain (★★) | +6: L310R at the same position is pathogenic; REVEL 0.981 | |
| MLH1 I25T | 25 | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; I25F at the same position is pathogenic; REVEL 0.932 | |
| MLH1 A125T | 125 | Uncertain (★★) | +6: 5 other pathogenic changes within 3 positions; A125E at the same position is pathogenic; REVEL 0.842 | |
| PMS2 P844T | 844 | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; P844H at the same position is pathogenic; REVEL 0.845 | |
| PMS2 S118I | 118 | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; S118T at the same position is pathogenic; REVEL 0.817 | |
| MLH1 Y684H | 684 | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; Y684D at the same position is pathogenic; REVEL 0.946 | |
| MLH1 C77G | 77 | Uncertain (★★) | +6: 4 other pathogenic changes within 3 positions; C77Y at the same position is pathogenic; REVEL 0.940 | |
| MSH2 V695A | 695 | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; V695M at the same position is pathogenic; REVEL 0.934 | |
| MSH2 N671H | 671 | Interaction with EXO1 | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; N671Y at the same position is pathogenic; REVEL 0.888 |
| MLH1 A128T | 128 | Uncertain (★★) | +6: 7 other pathogenic changes within 3 positions; A128P at the same position is pathogenic; REVEL 0.855 | |
| PMS2 P844S | 844 | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; P844H at the same position is pathogenic; REVEL 0.784 | |
| MLH1 R127G | 127 | Uncertain (★★) | +6: 7 other pathogenic changes within 3 positions; R127T at the same position is pathogenic; REVEL 0.865 | |
| MLH1 E34D | 34 | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; E34A at the same position is pathogenic; REVEL 0.826 | |
| MLH1 K311N | 311 | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; K311E at the same position is pathogenic; REVEL 0.830 |
Which prediction tools work for Lynch syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- EVE: 94 out of 100
- AlphaMissense: 92 out of 100
- CATVariant: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaGenome (regulatory): 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 88 out of 100
- SIFT: 87 out of 100
- MetaLR: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 86 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 86 out of 100
- MutPred: 86 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 78 out of 100
- AlphaGenome (splicing): 71 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 64 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 34 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Diseases related to Lynch syndrome
- Colorectal cancer, also linked to CHEK2, CTNNA1, MLH1, MLH3 and 2 more
- Gastric cancer, also linked to CHEK2, EPCAM, MLH1, MSH6 and 1 more
- Breast and/or ovarian cancer, also linked to CHEK2, MLH1, MSH2, MSH6 and 1 more
- Endometrial carcinoma, also linked to MLH1, MLH3, MSH2, MSH6 and 1 more
- Ovarian cancer, also linked to MLH1, MSH2, MSH6 and PMS1
- Hereditary breast ovarian cancer syndrome, also linked to CHEK2, MLH1, MSH2 and PMS2
- Colon carcinoma, also linked to MLH1, MSH2, MSH6 and PMS2
- Mismatch repair cancer syndrome, also linked to MLH1, MSH2, MSH6 and PMS2
- Hereditary breast cancer, also linked to CHEK2, EPCAM and MLH1
- Muir-Torré syndrome, also linked to MLH1 and MSH2
- Lynch-like syndrome, also linked to MLH1 and MSH6
- Familial thoracic aortic aneurysm and aortic dissection, also linked to TGFBR2
Frequently asked questions
Which genes have records linked to Lynch syndrome?
This view contains 10 analyzed proteins: MLH1, MSH2, MSH6, PMS2, CHEK2 and 5 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 189 pathogenic or likely pathogenic variants, 5,385 variants of uncertain significance and 1,342 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 37 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 7,499 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center